{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:14:47Z","timestamp":1707524087102},"reference-count":9,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,6,14]]},"DOI":"10.7759\/cureus.8619","type":"journal-article","created":{"date-parts":[[2020,6,14]],"date-time":"2020-06-14T19:26:35Z","timestamp":1592162795000},"source":"Crossref","is-referenced-by-count":0,"title":["Endobronchial Malignant Melanoma: An Exceedingly Rare Occurrence"],"prefix":"10.7759","author":[{"given":"Marium","family":"Ghani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara R","family":"Skavroneck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiran","family":"Adlakha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfred","family":"Papali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1080\/02841860310018053","article-title":"Endobronchial metastases from extrapulmonary solid tumors","volume":"43","author":"S\u00f8rensen JB","year":"2004","unstructured":"S\u00f8rensen JB. Endobronchial metastases from extrapulmonary solid tumors. Acta Oncol. 2004, 43:73-9. 10.1080\/02841860310018053","journal-title":"Acta Oncol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2014.03.005","article-title":"Endobronchial metastasis: an epidemiologic and clinicopathologic study of 174 consecutive cases","volume":"84","author":"Marchioni A","year":"2014","unstructured":"Marchioni A, Lasagni A, Busca A, et al.. Endobronchial metastasis: an epidemiologic and clinicopathologic study of 174 consecutive cases. Lung Cancer. 2014, 84:222-8. 10.1016\/j.lungcan.2014.03.005","journal-title":"Lung Cancer"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/crj.12456","article-title":"Endobronchial metastases from melanoma: a survival analysis","volume":"11","author":"Chaussende A","year":"2017","unstructured":"Chaussende A, Hermant C, Tazi\u2010Mezalek R, et al.. Endobronchial metastases from melanoma: a survival analysis. Clin Respir J. 2017, 11:1006-11. 10.1111\/crj.12456","journal-title":"Clin Respir J"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2018-228957","article-title":"Endobronchial, laryngeal and mediastinal melanoma: a rare constellation of metastatic disease","volume":"12","author":"Martinez Pena GN","year":"2019","unstructured":"Martinez Pena GN, Jiang C. Endobronchial, laryngeal and mediastinal melanoma: a rare constellation of metastatic disease. BMJ Case Rep. 2019, 12:e228957. 10.1136\/bcr-2018-228957","journal-title":"BMJ Case Rep"},{"key":"ref5","article-title":"Interleukin-2 for the treatment of melanoma","volume":"6","author":"Tarhini AA","year":"2005","unstructured":"Tarhini AA, Agarwala SS. Interleukin-2 for the treatment of melanoma. Curr Opin Investig Drugs. 2005, 6:1234-9.","journal-title":"Curr Opin Investig Drugs"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1504030","article-title":"Combined nivolumab and ipilimumab or monotherapy in untreated melanoma","volume":"373","author":"Larkin J","year":"2015","unstructured":"Larkin J, Chiarion-Sileni V, Gonzalez R, et al.. Combined nivolumab and ipilimumab or monotherapy in untreated melanoma. N Engl J Med. 2015, 373:23-34. 10.1056\/NEJMoa1504030","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6606030","article-title":"Targeting BRAF for patients with melanoma","volume":"104","author":"Arkenau HT","year":"2011","unstructured":"Arkenau HT, Kefford R, Long GV. Targeting BRAF for patients with melanoma. Br J Cancer. 2011, 104:392-8. 10.1038\/sj.bjc.6606030","journal-title":"Br J Cancer"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-16-0906","article-title":"A pilot trial of the combination of vemurafenib with adoptive cell therapy in patients with metastatic melanoma","volume":"23","author":"Deniger DC","year":"2017","unstructured":"Deniger DC, Kwong ML, Pasetto A, et al.. A pilot trial of the combination of vemurafenib with adoptive cell therapy in patients with metastatic melanoma. Clin Cancer Res. 2017, 23:351-62. 10.1158\/1078-0432.CCR-16-0906","journal-title":"Clin Cancer Res"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1103782","article-title":"Improved survival with vemurafenib in melanoma with BRAF V600E mutation","volume":"364","author":"Chapman PB","year":"2011","unstructured":"Chapman PB, Hauschild A, Robert C, et al.. Improved survival with vemurafenib in melanoma with BRAF V600E mutation. N. Eng J Med. 2011, 364:2507-16. 10.1056\/NEJMoa1103782","journal-title":"N. Eng J Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/28448-endobronchial-malignant-melanoma-an-exceedingly-rare-occurrence","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:23:20Z","timestamp":1707506600000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/28448-endobronchial-malignant-melanoma-an-exceedingly-rare-occurrence"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,14]]},"references-count":9,"URL":"https:\/\/doi.org\/10.7759\/cureus.8619","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6,14]]}}}